{"log_id": 3703519265372825427, "direction": 0, "words_result_num": 104, "words_result": [{"probability": {"variance": 0.050776, "average": 0.826758, "min": 0.372925}, "location": {"width": 945, "top": 41, "height": 116, "left": 746}, "words": "体阳性和谷丙转氨(ALT增、不有"}, {"probability": {"variance": 0.005505, "average": 0.951558, "min": 0.771202}, "location": {"width": 222, "top": 54, "height": 41, "left": 1219}, "words": "动性乙型肝炎病"}, {"probability": {"variance": 0.036467, "average": 0.839733, "min": 0.364177}, "location": {"width": 870, "top": 116, "height": 68, "left": 763}, "words": "ild分类A)的成年急经性丙型肝炎病人、尖耐、带状"}, {"probability": {"variance": 0.037131, "average": 0.844776, "min": 0.429075}, "location": {"width": 811, "top": 154, "height": 65, "left": 753}, "words": "小儿病性肺炎及上呼吸道感染。慢性宫颈,丁型肝炎"}, {"probability": {"variance": 0.025054, "average": 0.877775, "min": 0.520005}, "location": {"width": 815, "top": 195, "height": 61, "left": 839}, "words": "肿:毛状细胞白血病、多发性骨痛,丰间杰会氏巴"}, {"probability": {"variance": 0.03892, "average": 0.797719, "min": 0.419994}, "location": {"width": 698, "top": 229, "height": 65, "left": 746}, "words": "搁,些性白血病以及卡波济氏瘤,肾,乳头状"}, {"probability": {"variance": 0.032484, "average": 0.759556, "min": 0.460046}, "location": {"width": 500, "top": 270, "height": 54, "left": 750}, "words": "蕈样芽肿。优、基底纽胞等"}, {"probability": {"variance": 0.008324, "average": 0.854465, "min": 0.763226}, "location": {"width": 71, "top": 311, "height": 34, "left": 753}, "words": "格]"}, {"probability": {"variance": 0.015893, "average": 0.906724, "min": 0.543786}, "location": {"width": 380, "top": 349, "height": 47, "left": 842}, "words": "0万国际单位/支(100万1U"}, {"probability": {"variance": 0.008542, "average": 0.928864, "min": 0.658764}, "location": {"width": 352, "top": 390, "height": 41, "left": 828}, "words": "0万国单位/(300万"}, {"probability": {"variance": 0.035218, "average": 0.846107, "min": 0.440633}, "location": {"width": 246, "top": 428, "height": 37, "left": 822}, "words": "50万国际单位/支"}, {"probability": {"variance": 0.047237, "average": 0.786863, "min": 0.432693}, "location": {"width": 157, "top": 465, "height": 37, "left": 818}, "words": "复后每瓶"}, {"probability": {"variance": 0.014541, "average": 0.893629, "min": 0.723117}, "location": {"width": 140, "top": 503, "height": 37, "left": 746}, "words": "法用量"}, {"probability": {"variance": 0.033711, "average": 0.855751, "min": 0.364375}, "location": {"width": 804, "top": 537, "height": 61, "left": 818}, "words": "无菌开启西林瓶,以1毫升灭菌注射用木注人西林轻摇"}, {"probability": {"variance": 0.011038, "average": 0.945537, "min": 0.658626}, "location": {"width": 332, "top": 575, "height": 41, "left": 739}, "words": "待完全溶解后可使用"}, {"probability": {"variance": 0.031276, "average": 0.814963, "min": 0.484918}, "location": {"width": 274, "top": 609, "height": 51, "left": 739}, "words": "1.毛状细胞白血病"}, {"probability": {"variance": 0.013882, "average": 0.90458, "min": 0.70509}, "location": {"width": 119, "top": 654, "height": 34, "left": 811}, "words": "起始剂量"}, {"probability": {"variance": 0.024434, "average": 0.898409, "min": 0.465766}, "location": {"width": 643, "top": 688, "height": 47, "left": 811}, "words": "每日300万国际单位,下载肌表射,16到24"}, {"probability": {"variance": 0.030863, "average": 0.833572, "min": 0.461175}, "location": {"width": 918, "top": 698, "height": 92, "left": 739}, "words": "差,则应将每目产量减少150国单位,成将用药如耐受性"}, {"probability": {"variance": 0.005583, "average": 0.958303, "min": 0.755875}, "location": {"width": 263, "top": 763, "height": 41, "left": 739}, "words": "3次,也可以同时减"}, {"probability": {"variance": 0.094568, "average": 0.677493, "min": 0.369973}, "location": {"width": 58, "top": 746, "height": 34, "left": 1589}, "words": "每"}, {"probability": {"variance": 0.047241, "average": 0.59174, "min": 0.391774}, "location": {"width": 143, "top": 774, "height": 37, "left": 1109}, "words": "u用数"}, {"probability": {"variance": 0.01592, "average": 0.839406, "min": 0.641546}, "location": {"width": 123, "top": 808, "height": 34, "left": 811}, "words": "维持剂量"}, {"probability": {"variance": 0.032777, "average": 0.900594, "min": 0.359253}, "location": {"width": 496, "top": 842, "height": 47, "left": 811}, "words": "每次300万际单位每周皮下"}, {"probability": {"variance": 0.023691, "average": 0.902196, "min": 0.456215}, "location": {"width": 626, "top": 876, "height": 58, "left": 736}, "words": "则每次剂量减少至15万国际,每同"}, {"probability": {"variance": 0, "average": 0.999416, "min": 0.999141}, "location": {"width": 54, "top": 856, "height": 41, "left": 1558}, "words": "性差"}, {"probability": {"variance": 0.004871, "average": 0.690609, "min": 0.62082}, "location": {"width": 65, "top": 918, "height": 37, "left": 804}, "words": "行程"}, {"probability": {"variance": 0.02111, "average": 0.880317, "min": 0.548552}, "location": {"width": 705, "top": 948, "height": 92, "left": 722}, "words": "用该药大约6个月以危,比实生决定基否"}, {"probability": {"variance": 0.034291, "average": 0.888327, "min": 0.410933}, "location": {"width": 602, "top": 989, "height": 58, "left": 733}, "words": "人继续用约或是对效不的病人终止"}, {"probability": {"variance": 5.7e-05, "average": 0.992359, "min": 0.981438}, "location": {"width": 130, "top": 972, "height": 37, "left": 1517}, "words": "良好的病"}, {"probability": {"variance": 0.016456, "average": 0.910925, "min": 0.587156}, "location": {"width": 849, "top": 1027, "height": 65, "left": 801}, "words": "注:对血小板威少症病人(血小板计数少5×103/升)或有"}, {"probability": {"variance": 0.051651, "average": 0.842046, "min": 0.368919}, "location": {"width": 530, "top": 1061, "height": 61, "left": 733}, "words": "出血险的病人,仪以皮下注组"}, {"probability": {"variance": 0.00012, "average": 0.987771, "min": 0.9725}, "location": {"width": 102, "top": 1082, "height": 37, "left": 1356}, "words": "素2a"}, {"probability": {"variance": 0.034965, "average": 0.885704, "min": 0.512804}, "location": {"width": 184, "top": 1106, "height": 41, "left": 777}, "words": "多发性骨瘤"}, {"probability": {"variance": 0.043218, "average": 0.831161, "min": 0.354126}, "location": {"width": 835, "top": 1140, "height": 61, "left": 801}, "words": "应用重组人干扰素2z300万月际单位,每周5次皮下或向注"}, {"probability": {"variance": 0.016631, "average": 0.900148, "min": 0.549487}, "location": {"width": 907, "top": 1174, "height": 68, "left": 729}, "words": "射。根据不同病人的利受,可将剂量逐加至最大受量(9"}, {"probability": {"variance": 0.012244, "average": 0.914247, "min": 0.665511}, "location": {"width": 914, "top": 1216, "height": 65, "left": 733}, "words": "万国际单位)每周3次。除病情迅速发展观受性极外,这剂量"}, {"probability": {"variance": 0.015263, "average": 0.886947, "min": 0.690967}, "location": {"width": 126, "top": 1257, "height": 37, "left": 763}, "words": "持续使用"}, {"probability": {"variance": 0.0338, "average": 0.841605, "min": 0.467596}, "location": {"width": 376, "top": 1294, "height": 47, "left": 777}, "words": "度恶性非何杰全氏巴瘤"}, {"probability": {"variance": 0.043269, "average": 0.806055, "min": 0.376637}, "location": {"width": 774, "top": 1332, "height": 58, "left": 818}, "words": "组人扰a2a作为化疗的助治疗(伴随成不伴随疗"}, {"probability": {"variance": 0.021893, "average": 0.890853, "min": 0.444447}, "location": {"width": 890, "top": 1366, "height": 65, "left": 736}, "words": "可以延长任度恶性非何杰金氏淋巴瘤病人的大病生在期和恶化生"}, {"probability": {"variance": 0.003868, "average": 0.902451, "min": 0.840258}, "location": {"width": 51, "top": 1407, "height": 34, "left": 736}, "words": "存期"}, {"probability": {"variance": 0.025179, "average": 0.855111, "min": 0.632954}, "location": {"width": 126, "top": 1442, "height": 41, "left": 794}, "words": "推荐剂"}, {"probability": {"variance": 0.042156, "average": 0.856107, "min": 0.402249}, "location": {"width": 657, "top": 1486, "height": 44, "left": 798}, "words": "在常规化疗结束后(成不伴随疗),每"}, {"probability": {"variance": 0.007546, "average": 0.952654, "min": 0.749631}, "location": {"width": 174, "top": 1496, "height": 37, "left": 1462}, "words": "次,每次300"}, {"probability": {"variance": 0.031231, "average": 0.866131, "min": 0.351346}, "location": {"width": 914, "top": 1517, "height": 65, "left": 722}, "words": "万国际单位,皮下注封组干扰素a23,至少治疗12周。重"}, {"probability": {"variance": 0.018098, "average": 0.903658, "min": 0.532774}, "location": {"width": 921, "top": 1551, "height": 68, "left": 719}, "words": "组人扰素n2a的治疗应该在病人从化放疗反应中一恢复就立即"}, {"probability": {"variance": 0.028704, "average": 0.865049, "min": 0.415344}, "location": {"width": 911, "top": 1596, "height": 58, "left": 722}, "words": "开始,一时间为化一放疗后46周,重人扰表u2治疗也可伴"}, {"probability": {"variance": 0.018121, "average": 0.892937, "min": 0.525748}, "location": {"width": 623, "top": 1630, "height": 61, "left": 719}, "words": "随规的化疗方案(如结合环磷酰,的松"}, {"probability": {"variance": 0.064378, "average": 0.709305, "min": 0.356201}, "location": {"width": 188, "top": 1651, "height": 37, "left": 1438}, "words": "新和霉"}, {"probability": {"variance": 0.024965, "average": 0.882261, "min": 0.52005}, "location": {"width": 870, "top": 1671, "height": 58, "left": 760}, "words": "进行。以28天为一周。在第22-26大,皮下或肌肉注射重组"}, {"probability": {"variance": 0.024266, "average": 0.868989, "min": 0.461281}, "location": {"width": 441, "top": 1705, "height": 44, "left": 729}, "words": "人T扰素n2600万国际单位海"}, {"probability": {"variance": 0.034117, "average": 0.880853, "min": 0.434173}, "location": {"width": 219, "top": 1746, "height": 41, "left": 746}, "words": "结合化疗进行"}, {"probability": {"variance": 8e-06, "average": 0.664027, "min": 0.661175}, "location": {"width": 58, "top": 1750, "height": 37, "left": 1068}, "words": "雪组"}, {"probability": {"variance": 0.046625, "average": 0.780115, "min": 0.381884}, "location": {"width": 452, "top": 1719, "height": 47, "left": 1137}, "words": "每平方体农正积、重组人表"}, {"probability": {"variance": 0.000222, "average": 0.975898, "min": 0.960981}, "location": {"width": 61, "top": 1781, "height": 37, "left": 719}, "words": "进行"}, {"probability": {"variance": 0.065903, "average": 0.675068, "min": 0.354113}, "location": {"width": 222, "top": 1818, "height": 44, "left": 763}, "words": "性性自由病"}, {"probability": {"variance": 0.048617, "average": 0.815567, "min": 0.397114}, "location": {"width": 832, "top": 1856, "height": 65, "left": 801}, "words": "组人扰素u用于慢性性白血病人。60%处慢性"}, {"probability": {"variance": 0.029334, "average": 0.887195, "min": 0.427332}, "location": {"width": 911, "top": 1894, "height": 65, "left": 715}, "words": "期的慢性白血病病人,不管是否普接受其他治疗,接受重组人"}, {"probability": {"variance": 0.023899, "average": 0.874433, "min": 0.453691}, "location": {"width": 503, "top": 1935, "height": 51, "left": 719}, "words": "干扰a2a治疗后可达到血液学缓解"}, {"probability": {"variance": 0.019599, "average": 0.898731, "min": 0.495975}, "location": {"width": 832, "top": 1973, "height": 58, "left": 787}, "words": "三分之二类病人在开始按受治疗最近18个月后取斜完全的血"}, {"probability": {"variance": 0.030731, "average": 0.837156, "min": 0.442519}, "location": {"width": 921, "top": 2007, "height": 65, "left": 712}, "words": "液级解。与细胞毒性化行个同,重人干扰禁x2能持续持细"}, {"probability": {"variance": 0.038706, "average": 0.870541, "min": 0.412584}, "location": {"width": 339, "top": 2051, "height": 41, "left": 719}, "words": "传学级解达40个月以"}, {"probability": {"variance": 0.063757, "average": 0.818961, "min": 0.383613}, "location": {"width": 123, "top": 2086, "height": 37, "left": 784}, "words": "荐剂量"}, {"probability": {"variance": 0.039603, "average": 0.81647, "min": 0.40139}, "location": {"width": 935, "top": 2116, "height": 95, "left": 695}, "words": "些设对年满18岁或以上的病人作重人于扰:2下机肉"}, {"probability": {"variance": 0.031742, "average": 0.839742, "min": 0.352451}, "location": {"width": 544, "top": 2158, "height": 58, "left": 736}, "words": "射8-12,推荐逐渐地加剂量的方案如"}, {"probability": {"variance": 0.00426, "average": 0.948709, "min": 0.828439}, "location": {"width": 109, "top": 2199, "height": 37, "left": 784}, "words": "第1-3天"}, {"probability": {"variance": 0.019945, "average": 0.902031, "min": 0.565191}, "location": {"width": 263, "top": 2209, "height": 37, "left": 1010}, "words": "每日30万际革位"}, {"probability": {"variance": 0.010403, "average": 0.942245, "min": 0.738365}, "location": {"width": 119, "top": 2236, "height": 34, "left": 784}, "words": "第4-6天"}, {"probability": {"variance": 0.004422, "average": 0.963298, "min": 0.794688}, "location": {"width": 267, "top": 2243, "height": 37, "left": 1007}, "words": "每日600万同际单位"}, {"probability": {"variance": 0.001431, "average": 0.966146, "min": 0.89597}, "location": {"width": 113, "top": 2274, "height": 41, "left": 780}, "words": "第7-84"}, {"probability": {"variance": 0, "average": 0.828979, "min": 0.828979}, "location": {"width": 34, "top": 2291, "height": 30, "left": 1010}, "words": "母"}, {"probability": {"variance": 0.014864, "average": 0.866592, "min": 0.670355}, "location": {"width": 119, "top": 2284, "height": 34, "left": 1150}, "words": "压际单位"}, {"probability": {"variance": 0.009783, "average": 0.946042, "min": 0.594009}, "location": {"width": 839, "top": 2349, "height": 61, "left": 777}, "words": "病人必须接受治疗至少8,要取得好的疗效至少需要治疗"}, {"probability": {"variance": 0.02949, "average": 0.879926, "min": 0.50603}, "location": {"width": 345, "top": 2387, "height": 44, "left": 709}, "words": "2周.然后,再由医生决"}, {"probability": {"variance": 0.023394, "average": 0.905081, "min": 0.422523}, "location": {"width": 510, "top": 2397, "height": 41, "left": 1051}, "words": "定是否对疗效良好的病人继续用药"}, {"probability": {"variance": 8.7e-05, "average": 0.986969, "min": 0.977631}, "location": {"width": 61, "top": 2408, "height": 34, "left": 1558}, "words": "对血"}, {"probability": {"variance": 0.029076, "average": 0.880831, "min": 0.415183}, "location": {"width": 880, "top": 2425, "height": 61, "left": 709}, "words": "液学参数未见任何改善终止月药。疗效良好的病人应继续用药"}, {"probability": {"variance": 0.026391, "average": 0.888701, "min": 0.390161}, "location": {"width": 914, "top": 2459, "height": 65, "left": 705}, "words": "直至取得完全的血液学,或考一用药多到18个月,所有达"}, {"probability": {"variance": 0.0154, "average": 0.907092, "min": 0.404614}, "location": {"width": 897, "top": 2497, "height": 65, "left": 712}, "words": "完全液学经解的病,为应续每日900万国际单位(最佳"}, {"probability": {"variance": 0.018061, "average": 0.916343, "min": 0.358979}, "location": {"width": 904, "top": 2531, "height": 71, "left": 709}, "words": "量)或90万国际单位每3次(最低剂量)进行治疗,以使其在"}, {"probability": {"variance": 0.028025, "average": 0.884484, "min": 0.414183}, "location": {"width": 921, "top": 2569, "height": 68, "left": 705}, "words": "尽可能短的时间内取行细胞遗传学经。冬管有见到开始治疗两尔"}, {"probability": {"variance": 0.037788, "average": 0.842713, "min": 0.462255}, "location": {"width": 469, "top": 2610, "height": 58, "left": 709}, "words": "后达到细胞遗传学银解乙,但尚未"}, {"probability": {"variance": 0.031027, "average": 0.87399, "min": 0.540487}, "location": {"width": 160, "top": 2627, "height": 37, "left": 1263}, "words": "组人干扰素"}, {"probability": {"variance": 0, "average": 0.990782, "min": 0.990782}, "location": {"width": 51, "top": 2627, "height": 37, "left": 1561}, "words": "性"}, {"probability": {"variance": 0.006254, "average": 0.946159, "min": 0.746604}, "location": {"width": 315, "top": 2651, "height": 44, "left": 705}, "words": "性白血病的最疗程"}, {"probability": {"variance": 0.005501, "average": 0.937855, "min": 0.760355}, "location": {"width": 280, "top": 2692, "height": 41, "left": 750}, "words": "慢性活动乙早肝炎"}, {"probability": {"variance": 0.025734, "average": 0.834417, "min": 0.480646}, "location": {"width": 568, "top": 2730, "height": 51, "left": 777}, "words": "组人于扰素.2a适合治疗伴有DV-DN"}, {"probability": {"variance": 0, "average": 0.787707, "min": 0.787707}, "location": {"width": 85, "top": 2743, "height": 37, "left": 1421}, "words": " Ibeag"}, {"probability": {"variance": 0.029514, "average": 0.874499, "min": 0.386389}, "location": {"width": 733, "top": 2760, "height": 68, "left": 733}, "words": "聚等病毒复制标志的成年性料活动性乙型肝炎"}, {"probability": {"variance": 0.009295, "average": 0.872405, "min": 0.741443}, "location": {"width": 123, "top": 2805, "height": 41, "left": 770}, "words": "推荐剂"}, {"probability": {"variance": 0.000783, "average": 0.983938, "min": 0.862608}, "location": {"width": 839, "top": 2839, "height": 61, "left": 770}, "words": "尚未定出治疗慢性活动性乙型肝炎的最佳治疗方案。通常以"}, {"probability": {"variance": 0.033992, "average": 0.865612, "min": 0.383084}, "location": {"width": 873, "top": 2877, "height": 65, "left": 736}, "words": "万单位,每3:皮下注射,共用6个月。如用药一个月后"}, {"probability": {"variance": 0.025906, "average": 0.861435, "min": 0.477776}, "location": {"width": 907, "top": 2915, "height": 65, "left": 702}, "words": "病毒复制标与或 HBEAG无下降。则可逐渐加人剂量并可进一步将剂"}, {"probability": {"variance": 6.5e-05, "average": 0.990961, "min": 0.971912}, "location": {"width": 534, "top": 2952, "height": 58, "left": 712}, "words": "整至人能够受的水平,如治疗3"}, {"probability": {"variance": 0.00795, "average": 0.950114, "min": 0.703519}, "location": {"width": 280, "top": 2969, "height": 37, "left": 1325}, "words": "月后没有改善,则应"}, {"probability": {"variance": 0.001598, "average": 0.955433, "min": 0.898206}, "location": {"width": 195, "top": 2993, "height": 41, "left": 702}, "words": "考虑停止治疗"}, {"probability": {"variance": 0.012749, "average": 0.93171, "min": 0.591274}, "location": {"width": 712, "top": 3065, "height": 61, "left": 767}, "words": "据报道对患有慢性乙型肝炎的儿童以每平方米体表面"}, {"probability": {"variance": 0.012441, "average": 0.920185, "min": 0.631079}, "location": {"width": 698, "top": 3103, "height": 61, "left": 715}, "words": "际单位进行治疗是安全的,但其治疗效果尚未定论"}, {"probability": {"variance": 0.020296, "average": 0.904841, "min": 0.380289}, "location": {"width": 842, "top": 3141, "height": 65, "left": 763}, "words": "警重组人卡扰素a2a对慢性乙型肝炎合并感染人类免疫缺"}, {"probability": {"variance": 0.026081, "average": 0.873154, "min": 0.491863}, "location": {"width": 544, "top": 3175, "height": 61, "left": 688}, "words": "泛病毒门的病人的疗效尚无定论"}, {"probability": {"variance": 0.001782, "average": 0.968721, "min": 0.896307}, "location": {"width": 219, "top": 3219, "height": 41, "left": 739}, "words": "急慢肝炎"}, {"probability": {"variance": 0.032865, "average": 0.853907, "min": 0.381536}, "location": {"width": 835, "top": 3254, "height": 65, "left": 767}, "words": "重组天扰尚2合治疗HCV抗体阳性,谷雨转氨酶(ALT"}, {"probability": {"variance": 0.042231, "average": 0.850502, "min": 0.390712}, "location": {"width": 911, "top": 3291, "height": 68, "left": 691}, "words": "增高和不伴肝失代成年慢性内呈肝炎病人。但没有未和组织"}], "language": -1}